ALIX promotes cell migration and invasion of head and neck squamous cell carcinoma by regulating the expression of MMP9, MMP14, VEGF-C.

[1]  K. Ding,et al.  Roles of exosomes in cancer chemotherapy resistance, progression, metastasis and immunity, and their clinical applications (Review) , 2021, International journal of oncology.

[2]  J. Chiou,et al.  Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers , 2021, Frontiers in Oncology.

[3]  Hui Wang,et al.  Plasma-Derived Exosomal ALIX as a Novel Biomarker for Diagnosis and Classification of Pancreatic Cancer , 2021, Frontiers in Oncology.

[4]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[5]  Masahide Takahashi,et al.  Detection of serum/salivary exosomal Alix in patients with oral squamous cell carcinoma. , 2020, Oral diseases.

[6]  N. D’Silva,et al.  Radiation resistance in head and neck squamous cell carcinoma: dire need for an appropriate sensitizer , 2020, Oncogene.

[7]  E. Rivero,et al.  Association between immunohistochemical expression of matrix metalloproteinases and metastasis in oral squamous cell carcinoma: Systematic review and meta‐analysis , 2019, Head & neck.

[8]  G. Jenster,et al.  Differential tissue expression of extracellular vesicle‐derived proteins in prostate cancer , 2019, The Prostate.

[9]  P. Chakravarty,et al.  The Dynamics of TGF-β Signaling Are Dictated by Receptor Trafficking via the ESCRT Machinery. , 2018, Cell reports.

[10]  T. Padera,et al.  Growth and Immune Evasion of Lymph Node Metastasis , 2018, Front. Oncol..

[11]  P. Chavrier,et al.  Cellular and Molecular Mechanisms of MT1-MMP-Dependent Cancer Cell Invasion. , 2016, Annual review of cell and developmental biology.

[12]  Xiubing Zhang,et al.  The role of Alix in the proliferation of human glioma cells. , 2016, Human pathology.

[13]  Bo Li,et al.  Elective versus therapeutic neck dissection in node-negative oral cancer: Evidence from five randomized controlled trials. , 2015, Oral oncology.

[14]  H. Husi,et al.  Programmed cell death 6 interacting protein (PDCD6IP) and Rabenosyn‐5 (ZFYVE20) are potential urinary biomarkers for upper gastrointestinal cancer , 2015, Proteomics. Clinical applications.

[15]  V. Grégoire,et al.  The Role of Neck Dissection in Squamous Cell Carcinoma of the Head and Neck , 2014, Current Treatment Options in Oncology.

[16]  Qing Zhou,et al.  Cetuximab inhibits oral squamous cell carcinoma invasion and metastasis via degradation of epidermal growth factor receptor. , 2014, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[17]  F. Perez,et al.  ESCRT Machinery Is Required for Plasma Membrane Repair , 2014, Science.

[18]  P. Jänne,et al.  The quest to overcome resistance to EGFR-targeted therapies in cancer , 2013, Nature Medicine.

[19]  Krzysztof Fink,et al.  [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis]. , 2012, Postepy higieny i medycyny doswiadczalnej.

[20]  K. Opeskin,et al.  Vascular Endothelial Growth Factor Receptor-3 Directly Interacts with Phosphatidylinositol 3-Kinase to Regulate Lymphangiogenesis , 2012, PloS one.

[21]  M. Taketo,et al.  Significance and mechanism of lymph node metastasis in cancer progression. , 2011, Cancer research.

[22]  P. Harari,et al.  Understanding resistance to EGFR inhibitors—impact on future treatment strategies , 2010, Nature Reviews Clinical Oncology.

[23]  V. Band,et al.  Endosomal-sorting complexes required for transport (ESCRT) pathway-dependent endosomal traffic regulates the localization of active Src at focal adhesions , 2010, Proceedings of the National Academy of Sciences.

[24]  N. Pedersen,et al.  Ubiquitination of alpha 5 beta 1 integrin controls fibroblast migration through lysosomal degradation of fibronectin-integrin complexes. , 2010, Developmental cell.

[25]  J. Raymond,et al.  Critical role of ESCRT machinery in EGFR recycling. , 2009, Biochemistry.

[26]  S. Gygi,et al.  Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis , 2007, The EMBO journal.

[27]  Y. Kudo,et al.  VEGF-C is associated with lymphatic status and invasion in oral cancer , 2007, Journal of Clinical Pathology.

[28]  E. Rosenthal,et al.  Matrix metalloproteases in head and neck cancer. , 2006, Head & neck.

[29]  R. Ling,et al.  Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer , 2004, Breast Cancer Research.

[30]  James S. Brown,et al.  The impact of neck dissection on health-related quality of life. , 2004, Archives of otolaryngology--head & neck surgery.

[31]  T. Yoshizaki,et al.  Cleavage of Syndecan-1 by Membrane Type Matrix Metalloproteinase-1 Stimulates Cell Migration* , 2003, Journal of Biological Chemistry.

[32]  M. Maki,et al.  The ALG-2-interacting Protein Alix Associates with CHMP4b, a Human Homologue of Yeast Snf7 That Is Involved in Multivesicular Body Sorting* , 2003, Journal of Biological Chemistry.

[33]  A. Calistri,et al.  AIP1/ALIX Is a Binding Partner for HIV-1 p6 and EIAV p9 Functioning in Virus Budding , 2003, Cell.

[34]  J. Bourhis,et al.  End points for new agents in induction chemotherapy for locally advanced head and neck cancers. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  A. Strongin,et al.  Processing of Integrin αv Subunit by Membrane Type 1 Matrix Metalloproteinase Stimulates Migration of Breast Carcinoma Cells on Vitronectin and Enhances Tyrosine Phosphorylation of Focal Adhesion Kinase* , 2002, The Journal of Biological Chemistry.

[36]  H. Mori,et al.  Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration , 2001, The Journal of cell biology.

[37]  J. Gruenberg,et al.  ALIX and the multivesicular endosome: ALIX in Wonderland. , 2014, Trends in cell biology.